120 related articles for article (PubMed ID: 2059672)
1. HI-6 and 2-PAM in sheep: pharmacokinetics and effects on muscle tissue following intramuscular injection.
Moore DH; Hayward IJ; Tucker FS; Lukey B
Biopharm Drug Dispos; 1991 Apr; 12(3):223-32. PubMed ID: 2059672
[TBL] [Abstract][Full Text] [Related]
2. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
Lukey BJ; Woodard CL; Clark CR; McCluskey MP
J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
[TBL] [Abstract][Full Text] [Related]
3. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.
Clement JG; Bailey DG; Madill HD; Tran LT; Spence JD
Biopharm Drug Dispos; 1995 Jul; 16(5):415-25. PubMed ID: 8527690
[TBL] [Abstract][Full Text] [Related]
4. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7.
Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P
Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700
[TBL] [Abstract][Full Text] [Related]
6. Trimedoxime and HI-6: kinetic comparison after intravenous administration to mice.
Milic B; Maksimovic M; Nedelijkovic M
Pharmacol Toxicol; 1996 Apr; 78(4):269-72. PubMed ID: 8861786
[TBL] [Abstract][Full Text] [Related]
7. HI-6 oxime (an acetylcholinesterase reactivator): blood plasma pharmacokinetics and organ distribution in experimental pigs.
Kuneš M; Květina J; Bureš J; Karasová JZ; Pavlík M; Tachecí I; Musílek K; Kuca K
Neuro Endocrinol Lett; 2014; 35 Suppl 2():191-6. PubMed ID: 25638385
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of phosphinates as potential pretreatments for nerve agents.
Anderson DR; Harris LW; Lieske CN; Lennox WJ
Life Sci; 1991; 48(25):2463-8. PubMed ID: 2046471
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators.
Hepnarova V; Muckova L; Ring A; Pejchal J; Herman D; Misik J; Hrabinova M; Jun D; Soukup O
Toxicol Appl Pharmacol; 2019 Nov; 383():114776. PubMed ID: 31629733
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
Spöhrer U; Thiermann H; Klimmek R; Eyer P
Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
[TBL] [Abstract][Full Text] [Related]
12. Superior efficacy of HI-6 dimethanesulfonate over pralidoxime methylsulfate against Russian VX poisoning in cynomolgus monkeys (Macaca fascicularis).
Reymond C; Jaffré N; Taudon N; Menneteau M; Chaussard H; Denis J; Castellarin C; Dhote F; Dorandeu F
Toxicology; 2018 Dec; 410():96-105. PubMed ID: 30218682
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular kinetics and dosage regimens for pralidoxime in buffalo calves (Bubalus bubalis).
Srivastava AK; Malik JK
Vet Res Commun; 2001 May; 25(4):301-9. PubMed ID: 11432431
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel.
Alkondon M; Rao KS; Albuquerque EX
J Pharmacol Exp Ther; 1988 May; 245(2):543-56. PubMed ID: 2452874
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
Worek F; Koller M; Thiermann H; Wille T
Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys.
Busker RW; Zijlstra JJ; Philippens IH; Groen B; Melchers BP
Toxicology; 1996 Sep; 112(3):183-94. PubMed ID: 8845039
[TBL] [Abstract][Full Text] [Related]
17. Oral kinetics and bioavailability of the cholinesterase reactivator HI-6 after administration of 2 different formulations of tablets to dogs.
Maksimović M; Jovanović D; Kovacević V; Bokonjić D
Toxicol Lett; 1987 Nov; 39(1):85-91. PubMed ID: 3672559
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
[TBL] [Abstract][Full Text] [Related]
19. Asoxime (HI-6) impact on dogs after one and tenfold therapeutic doses: assessment of adverse effects, distribution, and oxidative stress.
Pohanka M; Novotny L; Zdarova-Karasova J; Bandouchova H; Zemek F; Hrabinova M; Misik J; Kuca K; Bajgar J; Zitka O; Cernei N; Kizek R; Pikula J
Environ Toxicol Pharmacol; 2011 Jul; 32(1):75-81. PubMed ID: 21787733
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of oximes in unanesthetized pigs.
Stemler FW; Tezak-Reid TM; McCluskey MP; Kaminskis A; Corcoran KD; Shih ML; Stewart JR; Wade JV; Hayward IJ
Fundam Appl Toxicol; 1991 Apr; 16(3):548-58. PubMed ID: 1855625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
